Top News

• Evo announced to be unveiled in the Indian market
• Already launched in Europe and other regions
• Availability of high-quality cancer treatment

Mumbai: ‘Elekta’ announced the unveiling of its latest linear accelerator, ‘Evo’, in the Indian market. Already launched in Europe and other regions, ‘Evo’ will now be available in India. That will bring high-resolution AI-enhanced imaging and its adaptive radiation therapy capabilities to clinicians across the country. This highly versatile CT-Linac will help clinicians select the most appropriate radiation therapy technique for each patient. ‘Evo’ was presented for the first time in India at the Association of Radiation Oncologists of India Conference (AROICON) in Kolkata, one of the country’s largest industry exhibitions in radiation oncology.

Feras Al Hasan, Head, TIMEA, Elekta said, “We are delighted to bring our flagship innovation, Evo Elekta, to India. Evo brings a new level of flexibility to India’s radiotherapy sector and is designed to enable care centers to deliver more efficient, personalized services. Its ability to support both online and offline adaptive treatment on CT-Linac ensures clinicians can adapt treatments based on daily physiological changes. Especially in India, where many patient complications and This is critical, as come with advanced disease. Our goal is to reinforce Elekta’s commitment to providing high-quality cancer care to more patients around the world.”

Fresh look, smart features and powerful speed! Vivo’s entry of two 5G smartphones with a bang, the price will come as a surprise

Shankar Seshadri, Vice President and Head – India Subcontinent said, “India needs radiotherapy solutions that combine precision and feasibility and ‘Evo’ is uniquely suited to meet India’s growing cancer burden and evolving patient needs. Its adaptive capacity and streamlined workflow help high-need centers treat more patients without compromising on quality of care. The arrival of ‘Evo’ in India is an important milestone as it represents our market presence in the region. will help accelerate growth.”

Adaptive radiotherapy, also known as adaptive radiation therapy or ART, is a treatment approach in which the radiation plan is modified during treatment to account for changes in the patient’s specific anatomy and/or tumor. Providing this treatment requires high-quality imaging, which enables clinicians to see tumors and organs at risk, ensuring an accurate diagnosis.

1. Iris High-Definition, AI-Enhanced/Improved Imaging: This allows the target area to be seen with greater clarity.
2. Elekta One Online: ** It provides AI-based automation for distributed treatment planning, rapid dose calculation and contouring and dose planning.

* Elekta ‘Evo’ has received Central Drugs Standard Control Organization (CDSCO) registration, but has limited global availability.

* Elekta One includes many Elekta solutions, some of which may not be available in all markets yet.

Samsung Galaxy Tab A11+: Samsung’s new tablet launched in India, equipped with 11-inch display and 7,040mAh battery… Know Price